CB Therapeutics
About this raise
CB Therapeutics, with a valuation of $45 million, is raising funds on Republic. The company has developed an advanced synthetic biology and cellular agriculture platform. The platform aims to discover, develop, and produce compounds to solve problems in the field of healthcare, food, mental health, and the environment. CB Therapeutics has a substantial patent portfolio with seven granted and 13 pending patents and has been generating revenues since 2022. She Ali Butt and Jacob Vogan founded CB Therapeutics in March 2015. The current crowdfunding campaign has a minimum target of $25,000 and a maximum target of $1.24 million. The campaign proceeds will be used for small-scale manufacturing, hiring of laboratory personnel, and research and development.
Investment Overview
Not Funded: $0
Deal Terms
Total Commitments
- Platform
- Republic
- Start Date
- 02/28/2023
- Close Date
- 04/11/2023
$25,000
$1,235,000
$250
SAFE
Growth Stage
RegCF
$45,000,000
20%
Company & Team
Company
- Year Founded
- 2015
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B
- Margin
- Medium
- Capital Intensity
- High
Financials
-
Revenue
-
$2,014,066
as of FY2021
- Monthly Burn
-
$147,680
as of FY2021
-
Runway
-
12.3 months
as of FY2021
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $7,600,000
- VC Backed?
- Yes
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 04/11/2023 | Republic | $45,000,000 | $0 | SAFE | Not Funded | RegCF |